GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » StemRIM Inc (TSE:4599) » Definitions » Net Margin %

StemRIM (TSE:4599) Net Margin % : 0.00% (As of Jan. 2024)


View and export this data going back to 2019. Start your Free Trial

What is StemRIM Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. StemRIM's Net Income for the three months ended in Jan. 2024 was 円-538 Mil. StemRIM's Revenue for the three months ended in Jan. 2024 was 円0 Mil. Therefore, StemRIM's net margin for the quarter that ended in Jan. 2024 was 0.00%.

The historical rank and industry rank for StemRIM's Net Margin % or its related term are showing as below:

TSE:4599' s Net Margin % Range Over the Past 10 Years
Min: -8479.75   Med: -41.6   Max: 16.56
Current: 7.63


TSE:4599's Net Margin % is ranked better than
81.23% of 1028 companies
in the Biotechnology industry
Industry Median: -154.37 vs TSE:4599: 7.63

StemRIM Net Margin % Historical Data

The historical data trend for StemRIM's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

StemRIM Net Margin % Chart

StemRIM Annual Data
Trend Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
Net Margin %
Get a 7-Day Free Trial -721.21 16.56 -41.60 -8,479.75 7.16

StemRIM Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 76.47 - - -

Competitive Comparison of StemRIM's Net Margin %

For the Biotechnology subindustry, StemRIM's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


StemRIM's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, StemRIM's Net Margin % distribution charts can be found below:

* The bar in red indicates where StemRIM's Net Margin % falls into.



StemRIM Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

StemRIM's Net Margin for the fiscal year that ended in Jul. 2023 is calculated as

Net Margin=Net Income (A: Jul. 2023 )/Revenue (A: Jul. 2023 )
=168.35/2350
=7.16 %

StemRIM's Net Margin for the quarter that ended in Jan. 2024 is calculated as

Net Margin=Net Income (Q: Jan. 2024 )/Revenue (Q: Jan. 2024 )
=-538.467/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


StemRIM  (TSE:4599) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


StemRIM Net Margin % Related Terms

Thank you for viewing the detailed overview of StemRIM's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


StemRIM (TSE:4599) Business Description

Traded in Other Exchanges
N/A
Address
7-15 Ayato Bio Incubator 3rd floor, Ayato Asagi 7-chome, Prefecture Ibaraki City, Osaka, JPN, 567-0085
StemRIM Inc is a biotechnology company engaged in developing regeneration-guided medicines. The business activity of the group includes research, development, manufacture, and sales of pharmaceuticals and medical devices and products such as gene therapy that activate stem cells existing in the body and induce regeneration of damaged tissue.

StemRIM (TSE:4599) Headlines

No Headlines